168 related articles for article (PubMed ID: 8894181)
1. Interaction of nitric oxide synthase inhibitors and their D-enantiomers with rat neutrophil luminol dependent chemiluminescence response.
Dikshit M; Chari SS; Seth P; Kumari R
Br J Pharmacol; 1996 Oct; 119(3):578-82. PubMed ID: 8894181
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the free radical generation and nitric oxide release from rat peripheral polymorphonuclear leukocytes following thrombosis.
Seth P; Kumari R; Dikshit M
Thromb Res; 1997 Aug; 87(3):279-88. PubMed ID: 9263395
[TBL] [Abstract][Full Text] [Related]
3. Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine.
Seth P; Kumari R; Dikshit M; Srimal RC
Blood; 1994 Oct; 84(8):2741-8. PubMed ID: 7919387
[TBL] [Abstract][Full Text] [Related]
4. Oxygen radicals and nitric oxide in rat mesenteric ischaemia-reperfusion: modulation by L-arginine and NG-nitro-L-arginine methyl ester.
Haklar G; Ulukaya-Durakbaşa C; Yüksel M; Dağli T; Yalçin AS
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):908-12. PubMed ID: 9807662
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors decrease human polymorphonuclear leukocyte luminol-dependent chemiluminescence.
Catz SD; Carreras MC; Poderoso JJ
Free Radic Biol Med; 1995 Dec; 19(6):741-8. PubMed ID: 8582646
[TBL] [Abstract][Full Text] [Related]
6. Prevention of doxorubicin-induced damage to rat heart myocytes by arginine analog nitric oxide synthase inhibitors and their enantiomers.
Barnabé N; Marusak RA; Hasinoff BB
Nitric Oxide; 2003 Dec; 9(4):211-6. PubMed ID: 14996428
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for luminol-augmented chemiluminescence from neutrophils induced by leukotriene B4 and N-formyl-methionyl-leucyl-phenylalanine.
Gyllenhammar H
Photochem Photobiol; 1989 Feb; 49(2):217-23. PubMed ID: 2540500
[TBL] [Abstract][Full Text] [Related]
9. Contribution of nitric oxide synthase to human neutrophil chemiluminescence.
Kudoh S; Suzuki K; Yamada M; Liu Q; Nakaji S; Sugawara K
Luminescence; 1999; 14(6):335-9. PubMed ID: 10602304
[TBL] [Abstract][Full Text] [Related]
10. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
11. Influence of nitric oxide on luminol-enhanced chemiluminescence measured from porcine-stimulated leukocytes.
Demiryürek AT; Kennedy S; Wainwright CL; Wadsworth RM; Kane KA
J Cardiovasc Pharmacol; 1997 Sep; 30(3):332-7. PubMed ID: 9300317
[TBL] [Abstract][Full Text] [Related]
12. Peroxynitrite augments fMLP-stimulated chemiluminescence by neutrophils in human whole blood.
Bednar MM; Balazy M; Murphy M; Booth C; Fuller SP; Barton A; Bingham J; Golding L; Gross CE
J Leukoc Biol; 1996 Nov; 60(5):619-24. PubMed ID: 8929553
[TBL] [Abstract][Full Text] [Related]
13. Luminol-dependent chemiluminescence is related to the extracellularly released reactive oxygen intermediates in the case of rat neutrophils activated by formyl-methionyl-leucyl-phenylalanine.
Németh K; Fûrész J; Csikor K; Schweitzer K; Lakatos S
Haematologia (Budap); 2002; 31(4):277-85. PubMed ID: 12038511
[TBL] [Abstract][Full Text] [Related]
14. Contribution of nitric oxide synthase to luminol-dependent chemiluminescence generated by phorbol-ester-activated Kupffer cells.
Wang JF; Komarov P; Sies H; de Groot H
Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):311-4. PubMed ID: 1718262
[TBL] [Abstract][Full Text] [Related]
15. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta.
Loomis ED; Sullivan JC; Osmond DA; Pollock DM; Pollock JS
J Pharmacol Exp Ther; 2005 Dec; 315(3):1058-64. PubMed ID: 16144972
[TBL] [Abstract][Full Text] [Related]
16. Redox activity associated with the maturation and capacitation of mammalian spermatozoa.
Aitken RJ; Ryan AL; Baker MA; McLaughlin EA
Free Radic Biol Med; 2004 Apr; 36(8):994-1010. PubMed ID: 15059640
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
Wanikiat P; Woodward DF; Armstrong RA
Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of nitric oxide synthase inhibitors on acetylcholine-induced relaxation of rat pulmonary and celiac artery rings.
Yaghi A; Paterson NA; McCormack DG
Can J Physiol Pharmacol; 1997 Apr; 75(4):279-86. PubMed ID: 9196853
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
